Weight-Loss Goal Planner
Set a realistic target weight and timeline — with and without GLP-1 therapy.
Weight-loss goal planner
Compare realistic timelines with and without GLP-1 therapy.
Estimates are based on average trial outcomes: lifestyle alone ~5%/year, GLP-1 (semaglutide 2.4 mg) ~15%/year, and tirzepatide ~20%/year over 12 months. Individual results vary considerably.
A tool is a starting point, not a diagnosis.
However your numbers come out, this is information — not a prescription. Bring your result to a consultation, and we'll put it in context with your history, labs, and what you actually feel.
Try another tool